Viewing Study NCT04272151

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:56 PM
Ignite Modification Date: 2026-05-18 @ 2:08 PM
Study NCT ID: NCT04272151
Status: UNKNOWN
Last Update Posted: 2023-04-18
First Post: 2020-02-13
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Safety and Efficacy of BCMA-Targeted CAR-T Therapy for Relapsed/Refractory Multiple Myeloma
Sponsor: Chongqing Precision Biotech Co., Ltd
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Neoplasm, Plasma Cell View
None Multiple Myeloma View
None Multiple Myeloma in Relapse View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Multiple Myeloma View
None Chimeric Antigen Receptor T cell View
None BCMA View